Targeting the CB2 cannabinoid receptor in osteoporosis

被引：2
|
作者：
Bab, Itai [1 ]
Ofek, Orr [1 ]
机构：
[1] Hebrew Univ Jerusalem, Bone Lab, Box 12272, IL-91120 Jerusalem, Israel
来源：
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM | 2011年 / 6卷 / 02期
关键词：
2-arachidonoylglycerol; age-related bone loss; arachidonoylethanoamine; bone density; bone mass; cannabinoid receptors; CB1; CB2; endocannabinoids; osteoporosis;
D O I：
10.1586/EEM.11.2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：135 / 138
页数：4
相关论文
共 50 条
  • [1] Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands
    Poso, A.
    Huffman, J. W.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (02) : 335 - 346
  • [2] Targeting the cannabinoid CB2 receptor:: Mutations, modeling and development of CB2 selective ligands
    Raitio, KH
    Salo, OMH
    Nevalainen, T
    Poso, A
    Järvinen, T
    [J]. CURRENT MEDICINAL CHEMISTRY, 2005, 12 (10) : 1217 - 1237
  • [3] Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies
    Steffens, Sabine
    Pacher, Pal
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2012, 167 (02) : 313 - 323
  • [4] The cannabinoid CB2 receptor:: A potential target for the diagnosis and treatment of osteoporosis.
    Karsak, M
    Ofek, O
    Fogel, M
    Wright, K
    Tam, J
    Gabet, Y
    Birenboim, R
    Attar-Namdar, M
    Müller, R
    Cohen-Solal, M
    de Vernejoul, M
    Shohami, E
    Mechoulam, R
    Zimmer, A
    Bab, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S383 - S383
  • [5] Cannabinoid Receptor CB2 Structure and CB2/Gi Signaling Mechanisms
    Xing, Changrui
    Zhang, Cheng
    Xie, Xiang-Qun
    [J]. FASEB JOURNAL, 2019, 33
  • [6] CB2: a cannabinoid receptor with an identity crisis
    Atwood, Brady K.
    Mackie, Ken
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (03) : 467 - 479
  • [7] Brain Cannabinoid CB2 Receptor in Schizophrenia
    Ishiguro, Hiroki
    Horiuchi, Yasue
    Ishikawa, Maya
    Koga, Minori
    Imai, Keiko
    Suzuki, Yoshimi
    Morikawa, Miyuki
    Inada, Toshiya
    Watanabe, Yuichiro
    Takahashi, Makoto
    Someya, Toshiyuki
    Ujike, Hiroshi
    Iwata, Nakao
    Ozaki, Norio
    Onaivi, Emmanuel S.
    Kunugi, Hiroshi
    Sasaki, Tsukasa
    Itokawa, Masanari
    Arai, Makoto
    Niizato, Kazuhiro
    Iritani, Shyuji
    Naka, Izumi
    Ohashi, Jun
    Kakita, Akiyoshi
    Takahashi, Hitoshi
    Nawa, Hiroyuki
    Arinami, Tadao
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (10) : 974 - 982
  • [8] CB2 cannabinoid receptor mediation of antinociception
    Ibrahim, Mohab M.
    Rude, Megan L.
    Stagg, Nicola J.
    Mata, Heriberto P.
    Lai, Josephine
    Vanderah, Todd W.
    Porreca, Frank
    Buckley, Nancy E.
    Makriyannis, Alexandros
    Malan, T. Philip, Jr.
    [J]. PAIN, 2006, 122 (1-2) : 36 - 42
  • [9] Emerging strategies targeting CB2 cannabinoid receptor: Biased agonism and allosterism
    Morales, Paula
    Goya, Pilar
    Jagerovic, Nadine
    [J]. BIOCHEMICAL PHARMACOLOGY, 2018, 157 : 8 - 17
  • [10] Cannabichromene is a cannabinoid CB2 receptor agonist
    Udoh, Michael
    Santiago, Marina
    Devenish, Steven
    McGregor, Iain S.
    Connor, Mark
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (23) : 4537 - 4547
12345